Cardiol Therapeutics Inc. (CRDL.TO)

CAD 1.58

(3.95%)

Total Liabilities Summary of Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.'s latest annual total liabilities in 2023 was 8.45 Million CAD , down -13.97% from previous year.
Cardiol Therapeutics Inc.'s latest quarterly total liabilities in 2024 Q2 was 10.95 Million CAD , down -1.04% from previous quarter.
Cardiol Therapeutics Inc. reported annual total liabilities of 9.82 Million CAD in 2022, down -15.56% from previous year.
Cardiol Therapeutics Inc. reported annual total liabilities of 11.63 Million CAD in 2021, up 343.72% from previous year.
Cardiol Therapeutics Inc. reported quarterly total liabilities of 11.06 Million CAD for 2024 Q1, up 30.91% from previous quarter.
Cardiol Therapeutics Inc. reported quarterly total liabilities of 8.45 Million CAD for 2023 Q4, up 3.32% from previous quarter.

Annual Total Liabilities Chart of Cardiol Therapeutics Inc. (2023 - 2017)

Historical Annual Total Liabilities of Cardiol Therapeutics Inc. (2023 - 2017)

Year	Total Liabilities	Total Liabilities Growth
2023	8.45 Million CAD	-13.97%
2022	9.82 Million CAD	-15.56%
2021	11.63 Million CAD	343.72%
2020	2.62 Million CAD	215.69%
2019	830.82 Thousand CAD	-65.53%
2018	2.41 Million CAD	557.28%
2017	366.75 Thousand CAD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	10.95 Million CAD	-1.04%
2024 Q1	11.06 Million CAD	30.91%
2023 Q4	8.45 Million CAD	3.32%
2023 Q2	8.41 Million CAD	18.08%
2023 Q1	7.12 Million CAD	-27.45%
2023 FY	8.45 Million CAD	-13.97%
2023 Q3	8.18 Million CAD	-2.81%
2022 Q2	11.41 Million CAD	11.69%
2022 Q4	9.82 Million CAD	1.5%
2022 FY	9.82 Million CAD	-15.56%
2022 Q1	10.21 Million CAD	-12.2%
2022 Q3	9.68 Million CAD	-15.17%
2021 Q1	2.85 Million CAD	9.01%
2021 FY	11.63 Million CAD	343.72%
2021 Q4	11.63 Million CAD	339.81%
2021 Q3	2.64 Million CAD	-12.15%
2021 Q2	3.01 Million CAD	5.35%
2020 Q1	826.44 Thousand CAD	-0.53%
2020 FY	2.62 Million CAD	215.69%
2020 Q4	2.62 Million CAD	32.3%
2020 Q3	1.98 Million CAD	50.86%
2020 Q2	1.31 Million CAD	59.01%
2019 Q4	830.82 Thousand CAD	-49.9%
2019 Q2	950.08 Thousand CAD	-2.73%
2019 Q1	976.78 Thousand CAD	-59.48%
2019 FY	830.82 Thousand CAD	-65.53%
2019 Q3	1.65 Million CAD	74.54%
2018 Q4	2.41 Million CAD	-85.21%
2018 Q1	- CAD	-100.0%
2018 Q2	11.21 Million CAD	0.0%
2018 FY	2.41 Million CAD	557.28%
2018 Q3	16.3 Million CAD	45.31%
2017 FY	366.75 Thousand CAD	0.0%
2017 Q4	366.75 Thousand CAD	0.0%

Peer Total Liabilities Comparison of Cardiol Therapeutics Inc.

Name	Total Liabilities	Total Liabilities Difference
Aurora Cannabis Inc.	236.8 Million CAD	96.43%
Avicanna Inc.	13.99 Million CAD	39.61%
Avant Brands Inc.	33.22 Million CAD	74.555%
Crescita Therapeutics Inc.	5.77 Million CAD	-46.364%
Knight Therapeutics Inc.	198.62 Million CAD	95.744%
MediPharm Labs Corp.	10.93 Million CAD	22.667%
OrganiGram Holdings Inc.	26.83 Million CAD	68.493%
Canopy Growth Corporation	799.82 Million CAD	98.943%
Willow Biosciences Inc.	3.23 Million CAD	-161.168%
Auxly Cannabis Group Inc.	210.85 Million CAD	95.991%